Methods-Results:
We retrospectively analyzed clinical, hematological, and angiographic data of 201 patients (mean age 59.8AE13.1 years, 74.6% men) who had undergone PCI for acute STEMI and a further control coronary angiography due to stable angina pectoris or acute coronary syndrome. Patients were divided into two groups according to developing stent thrombosis (n¼147) or not (n¼54). Age, sex, hemoglobin, C-reactive protein, stent type and length, pre and post-dilatation of the stent did not differ between groups. The pre-procedural PLR was significantly higher in patients with stent thrombosis compared to patients without stent thrombosis (176AE68 vs. 135AE62; p<0.001). The NLR was positively correlated with PLR (r:0.623, p<0.001) but did not differ between two groups (p¼0.702) After multiple logistic regression analysis, pre-procedural PLR remained significant predictor of stent thrombosis (OR: 1.009, 95% confidence interval: 1.004-1.014, p<0.001). In receiver operating characteristics analysis, the PLR> 150 had 63% sensitivity and 70% specificity in predicting stent thrombosis. Conclusıon: High pre-procedural PLR is a significant and independent predictor of stent thrombosis in patients with acute STEMI.
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Is the Results: Glu298Asp polymorphism of the study and control groups were no significant differences between the distributions of GG (p¼0.860), GT (p¼0.970), TT (p¼0.838). Acute, subacute, late and very late stent thrombosis period, there wasn't any statistically significant difference between the groups of the distribution of Glu298Asp (p¼0.478). There was no significant difference in the distribution of polymorphism Glu298Asp between the groups of acute (p¼0.533), subacute (p¼0.469), late (p¼0.975) and very late (p¼0.975) stent trombosis and the control group. Conclusıon: Acquired defects in the formation of NO are associated in increased risk factors of cardiovascular disease NO concentrations fluctuate on a regular basis. Its low concentrations are favorable and high concentrations have a toxic effect. Either the decrease in the activity of NOS or over-stimulation of NO may play a role in the development of stent trombosis. The deterioration of eNOS activity may play a role in the development of stent thrombosis, suggesting that the publications available. In our study, analysis of patients with and without stent thrombosis, endothelial nitric oxide synthase Glu298Asp gene polymorphism was not significantly different. According to the time of stent thrombosis developed was classified as acute, subacute, late and too late there was not a significant different between the time of stent trombosis in the patients with the Glu298Asp gene polymorphism.
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Distribution of Atrial Septal Defect Types in Young Turkish Popülation and Percutaneous Closure of Secundum Atrial Septal Defects; 163 Cases Hasan Arı, Nadir Emlek, Serdar Keçeo glu, _ Ibrahim Aktaş, Ahmet Tütüncü, Gökhan Özmen, Kubra Do ganay, Selvi Coşar, Tufan Günay, Mehmet Demir, Mehmet Melek, Tahsin Bozat, Vedat Koca Bursa Postgraduate Hospital, Bursa
Objectıves: In this study, we evaluated distribution of atrial septal defect (ASD) types which were diagnosed by transesophageal echocardiography (TEE). Also we evaluated shunt ratio with cardiac catheterization and investigated results of percutaneous closure of secundum ASD in our clinic. Method and Results: We retrospectively evaluated 163 ASD cases between 2005 and 2013. The mean age of the patients was 36.7AE15.1 (year), female/male ratio was; 111 (68.1%) / 52 (31.9%9). 119 (73%) cases were ostium secundum type, 29 (17.8%) cases were sinüs venosus type (21 cases superior vena cava type, 8 cases inferior vena cava type), 14 (8.6%) cases were ostium primum type and 1 (0.6%) case was coronary sinüs type ASD. 89 cases were treated with surgery, 58 cases were treated with pecutaneous tecnique and 16 cases were treated medically after cardiac catheterization. Mean age of the secundum ASD cases which treated with percutaneous tecnique was 36.5AE14.9 (year) and according to TEE measurement, mean defect diameter was: 20.3AE14.6 mm, mean anterior superior rim was: 4.8AE3.4 mm, mean anterior inferior rim was:18.3AE16.9 mm, mean posterior superior rim was: 20.8AE15.4 mm, mean posterior inferior rim was: 17.7AE0.8 mm. According to cardiac catheterization the cases mean Qp/Qs ratio was: 2.3AE1.0. Device size used for percutaneous closure of ASD was: 22.8AE6.8 mm. Devices used for percutaneous closure were Amplatzer 46.6% (27 cases), Lifetech 31% (18 cases), Cardiofix 12.1% (7 cases) and other 10.3% (6 cases). We never used double device for the cases. The percutaneous closure procedure was successful at 57 of 58 (98.2%) patients. In 1 patient procedure was failed, because the device was not stabile with Minnesota maneuver, so the patient referred to surgery. During follow up 1 more patient referred to surgery because of device embolization and we showed residuel shunt in 1 patient in first day control. Thrombus on devices, device erosion or death is not observed after the procedure. Conclusıon: Distribution of atrial septal defect types in young Turkish popülation was; respectively: secundun ASD, sinüs venosus ASD and ostium primum ASD. Percutaneous closure of secundum ASD which replaced surgical treatment of secundum ASD is safe and effective method. However because of potentially serious complication risks it should be performed in special centers which are experienced in treating ASD.
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The Use of Bioresorbable Coronary Scaffold in the Chronic Total Occlusion Because of the length of the lesion in chronic total occlusions (CTO), sometimes more than one stents are used and a metal jacket is prepared. The application of bioresorbable scaffolds in such lesions appears quite attractive. However, the use of these devices may be limited due to former occlusions in CTOs and as most of them may contain serious calcifications. Excluding a case presentation published in the literature of BCS use in CTO, there is no any data. 
